Cargando…
Exosomes as Drug Carriers in Anti-Cancer Therapy
Over the years, there has been a high demand for developing new safe and effective drug carriers for cancer therapy. Emerging studies have indicated that exosomes can serve as potent therapeutic carriers since they offer low immunogenicity, high stability, innate and acquired targetability, and the...
Autores principales: | Chen, Lan, Wang, Li, Zhu, Lingling, Xu, Zihan, Liu, Yanyang, Li, Zhixi, Zhou, Jin, Luo, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826094/ https://www.ncbi.nlm.nih.gov/pubmed/35155421 http://dx.doi.org/10.3389/fcell.2022.728616 |
Ejemplares similares
-
Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma
por: Zhu, Lingling, et al.
Publicado: (2022) -
Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
por: He, Yingying, et al.
Publicado: (2021) -
Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer
por: Zeng, Ye, et al.
Publicado: (2020) -
Exosomal miR-500 Derived From Lipopolysaccharide-Treated Macrophage Accelerates Liver Fibrosis by Suppressing MFN2
por: Chen, Lisha, et al.
Publicado: (2021) -
Exosome-Based Delivery of Natural Products in Cancer Therapy
por: Song, Hang, et al.
Publicado: (2021)